Bromperidol Decanoate

Comparative bioavailability study of two haloperidol decanoate containing products
By van Weringh G; Komen B J; Thieme R E; van der Hoeven R T; Vos T
From Pharmacy world & science : PWS (1994), 16(6), 243-7.
 
Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects
By Meco G; Casacchia M; Attenni M; Iafrate A; Castellana F; Ecari U
From Acta psychiatrica Belgica (1983), 83(1), 57-68

Bromperidol Decanoate is chemically 4-(4-Bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)piperidin-4-yl decanoate. Bromperidol Decanoate is supplied with detailed characterization data compliant with regulatory guideline. Bromperidol Decanoate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Haloperidol Decanoate.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.